Close Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Close Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,152	Closed	-$250K	–	235
2021 Q1	$250K	Hold	1,152	–	–	0.01%	96
2020 Q4	$133K	Buy	1,152 +210	+22%	+$23.5K	0.01%	85
2020 Q3	$92K	Buy	942 +61	+7%	+$7.02K	0.01%	94
2020 Q2	$108K	Hold	881	–	–	0.01%	92
2020 Q1	$77K	Sell	881 -100	-10%	-$10.6K	0.01%	100
2019 Q4	$103K	Buy	981 +105	+12%	+$11.8K	0.01%	99
2019 Q3	$101K	Hold	876	–	–	0.01%	102
2019 Q2	$151K	Buy	876 +104	+13%	+$18K	0.01%	99
2019 Q1	$130K	Sell	772 -228	-23%	-$33.9K	0.01%	103
2018 Q4	$10K	Buy	1,000 +233	+30%	+$30.6K	﹤0.01%	158
2018 Q3	$133K	Sell	767 -47	-6%	-$6.78K	0.01%	104
2018 Q2	$86K	Hold	814	–	–	0.01%	113
2018 Q1	$86K	Sell	814 -20	-2%	-$2.52K	0.01%	116
2017 Q4	$110K	Hold	834	–	–	0.01%	105
2017 Q3	$85K	Hold	834	–	–	0.01%	110
2017 Q2	$84K	Buy	+834	New	+$89.8K	0.01%	111

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Close Asset Management's GWPH Position: Q2 2021 in Review

Close Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,152 shares — an estimated $250K sold.

Close Asset Management first reported a position in GWPH in Q2 2017 and held it in 16 quarters. The position peaked at $250K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Close Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Close Asset Management sold 1,152 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $250K.
Close Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 16 quarters.
Close Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $250K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Close Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.